One-year outcomes of bioresorbable magnesium scaffold implantation in complex coronary lesions
Frontiers in Cardiovascular Medicine · 12.06.2026 · 13
DOI: 10.3389/fcvm.2026.1854686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 12.06.2026. Verfasst von Simon Wölbert und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Cardiovascular Center Oberallgäu-Kempten, Kempten, Germany. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Magmaris is a bioresorbable magnesium scaffold that has shown favorable safety and efficacy in the treatment of de-novo coronary lesions.
Aims
To report 1-year outcomes after Magmaris implantation in patients with predominantly complex coronary lesions in the Resorbable Magnesium Scaffold registry (RMS) and to compare them with outcomes from patients with mainly non-complex lesions in the BIOSOLVE-IV registry.
Methods
The RMS registry is an ongoing, prospective, national, multicenter registry conducted in Germany. Enrollment took place from November 2020 until May 2023 at Cardiovascular Center Oberallgaeu-Kempten, Bavaria, Germany. Follow-up was performed by phone 12 months after index procedure. We report 1-year outcomes of the first 100 consecutively enrolled patients and provide an unadjusted statistical comparison with 1-year outcomes from the BIOSOLVE-IV registry.
Results
RMS patients were older (64.9 ± 8.5 vs. 61.9 ± 10.5 years; p = 0.006) and had a significantly more complex lesion profile ( p < 0.001), with higher rates of type B2/C lesions (74.0% vs. 15.1%) and moderate-to-severe calcification (24.0% vs. 7.5%), whereas lesion length was similar between the registries ( p = 0.118). At 12 months, target-lesion failure did not differ significantly between RMS and BIOSOLVE-IV ( p = 0.885), while scaffold thrombosis was numerically more frequent in RMS (2.0% vs. 0.8%; p = 0.384).
Conclusion
Despite a more complex lesion profile in RMS, no statistically significant differences in 1-year clinical outcomes were observed between the two registries. This analysis is hypothesis-generating though not conclusive. Conclusive analysis can only be provided by a randomized controlled trial. Clinical Trial Registration RMS registry, NCT04679740.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Cardiovascular Center Oberallgäu-Kempten, Kempten, Germany.
- Department of Internal Medicine I, University Hospital Augsburg, Augsburg, Germany.
- Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.
Zitieren
APA
Wölbert, S., Schmidt, T., Wittek, F., Mayer, B., Raake, P., Bongiovanni, D., & Torzewski, J. (2026). One-year outcomes of bioresorbable magnesium scaffold implantation in complex coronary lesions. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1854686
Vancouver
Wölbert S, Schmidt T, Wittek F, Mayer B, Raake P, Bongiovanni D, et al. One-year outcomes of bioresorbable magnesium scaffold implantation in complex coronary lesions. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1854686
BibTeX
@article{Wlbert2026,
author = {Wölbert, Simon and Schmidt, Thomas and Wittek, Fabian and Mayer, Benjamin and Raake, Philip and Bongiovanni, Dario and Torzewski, Jan},
title = {One-year outcomes of bioresorbable magnesium scaffold implantation in complex coronary lesions},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1854686}
}
EUVIMED